Código QR (código de barras bidimensional)

Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives

Abstract Background A 12-dose, once-weekly regimen of isoniazid and rifapentine (3HP) is effective in preventing tuberculosis (TB) among people living with HIV (PLHIV). We sought to identify potential barriers to and facilitators of acceptance and completion of 3HP treatment from the perspective of...

ver descrição completa

Na minha lista:
Principais autores: Fred C. Semitala, Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota, Christopher A. Berger, Achilles Katamba, Noah Kiwanuka, Moses R. Kamya, David Dowdy, Adithya Cattamanchi, Anne R. Katahoire
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2021-06-01
coleção:Implementation Science Communications
Assuntos:
Tuberculosis
Preventive therapy
Perceived barriers
Perceived facilitators
People living with HIV
Health workers
Acesso em linha:https://doi.org/10.1186/s43058-021-00173-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados